(A) Heatmap showing scaled relative expression levels of polysaccharide utilization loci (PULs) in B. theta RNA transcripts sequenced from stool collected from meropenem-treated allo-HSCT mice with or without administration of B. ovatus on day 21. Right: PULs and their modularity and substrate names. (B) Relative expression levels of PULs in B. theta RNA transcripts sequenced from stool collected on day 21 from meropenem-untreated allo-HSCT mice with or without administration of B. ovatus. Right: PULs and their modularity.
(C) Relative abundances of monosaccharides of supernatants from colonic luminal content collected from germ-free (GF) mice with or without administration of B. ovatus on day 14 measured by IC-MS. Data are shown from one representative experiment. (D) Relative abundances of monosaccharides of supernatants from colonic luminal content collected from meropenem-untreated allo-HSCT mice with or without administration of B. ovatus on day 23 measured by ion chromatography-mass spectrometry (IC-MS). Data are shown from one representative experiment.
(E) Absolute abundances of tryptophan metabolites of supernatants from colonic luminal content collected from meropenem-treated allo-HSCT mice with or without administration of B. ovatus on day 23 measured by liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS). Data are combined from two independent experiments and are shown as means ± SEM.